Medical device recalls Moderate risk

Detect Headquarters recalls Detect Covid-19 Test Product/Model Number: 21205

Recall date
December 8, 2022
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-0879-2023
FDA classification
Class II
Brand / firm
Detect Headquarters
Sold / distributed
Domestic distribution nationwide. Foreign distribution to Hong Kong.

Why it was recalled

There is an increased chance that the tests from affected lots may give false negative results. Health risks resulting from a false negative result include delay or lack of supportive treatment and lack of monitoring of infected individuals and their household or other close contacts for symptoms resulting in increased risk of spread of COVID-19 within the community.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Detect Covid-19 Test Product/Model Number: 21205

Get recall alerts

Free email alert whenever Detect Headquarters has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Detect Headquarters